Fenton-Lee D, Imrie C W
Department of Surgery, Glasgow Royal Infirmary, UK.
Br J Surg. 1993 Dec;80(12):1579-82. doi: 10.1002/bjs.1800801228.
Ten patients with necrotizing pancreatitis admitted consecutively between August 1990 and August 1991 were studied. They comprised eight men and two women of median age 63 (range 29-73) years. One patient died. The median length of hospital stay was 74 (range 40-150) days. The median number of operations and endoscopic procedures performed per patient was 4 (range 2-7). Investigations performed included multiple bacteriological, radiological, haematological and biochemical tests. The mean cost of management was 18,441 pounds (range 9,296 pounds-33,796 pounds), of which hospitalization accounted for 65 per cent, operations and endoscopic procedures 20 per cent and investigations 16 per cent. Cost-utility analysis demonstrated a mean benefit per patient of 8.55 quality-adjusted life years gained at a cost of 2,157 pounds each. The management of pancreatic necrosis is expensive but justified by the excellent outcome in terms of quality of life.
对1990年8月至1991年8月期间连续收治的10例坏死性胰腺炎患者进行了研究。他们包括8名男性和2名女性，年龄中位数为63岁（范围29 - 73岁）。1例患者死亡。住院时间中位数为74天（范围40 - 150天）。每位患者接受手术和内镜检查的中位数为4次（范围2 - 7次）。进行的检查包括多项细菌学、放射学、血液学和生化检查。管理的平均费用为18441英镑（范围9296英镑 - 33796英镑），其中住院费用占65%，手术和内镜检查费用占20%，检查费用占16%。成本效益分析表明，每位患者平均获得8.55个质量调整生命年，每个质量调整生命年的成本为2157英镑。胰腺坏死的治疗费用高昂，但从生活质量的优异结果来看是合理的。
